Correlation Between 4D Molecular and Ascendis Pharma
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Ascendis Pharma AS, you can compare the effects of market volatilities on 4D Molecular and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Ascendis Pharma.
Diversification Opportunities for 4D Molecular and Ascendis Pharma
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between FDMT and Ascendis is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of 4D Molecular i.e., 4D Molecular and Ascendis Pharma go up and down completely randomly.
Pair Corralation between 4D Molecular and Ascendis Pharma
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Ascendis Pharma. In addition to that, 4D Molecular is 1.84 times more volatile than Ascendis Pharma AS. It trades about -0.06 of its total potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.01 per unit of volatility. If you would invest 12,769 in Ascendis Pharma AS on August 24, 2024 and sell it today you would earn a total of 1.00 from holding Ascendis Pharma AS or generate 0.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Ascendis Pharma AS
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Ascendis Pharma AS |
4D Molecular and Ascendis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Ascendis Pharma
The main advantage of trading using opposite 4D Molecular and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.| 4D Molecular vs. Revolution Medicines | 4D Molecular vs. Black Diamond Therapeutics | 4D Molecular vs. Passage Bio | 4D Molecular vs. Century Therapeutics |
| Ascendis Pharma vs. Lyra Therapeutics | Ascendis Pharma vs. Hookipa Pharma | Ascendis Pharma vs. Cingulate Warrants | Ascendis Pharma vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |